Follow-up PET-CT scans for colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at whether a special type of PET-CT scan (called FDG PET-CT) can help doctors see how well your colorectal cancer treatment worked and what might happen in the future. You'll have this scan during follow-up visits to monitor your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colorectal cancer.
- You have already received treatment for your colorectal cancer.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan called 18F-FDG to see how well your first chemotherapy is working, just a couple of weeks after you start. The goal is to find out early whether the treatment is helping, so you and your doctor can decide together if you should continue or switch to a different approach.
This trial is testing whether adding a PET/CT scan to routine follow-up care helps patients with stage III non-small cell lung cancer. It aims to see if this extra imaging can detect any return of cancer earlier, which may help with treatment decisions.
This trial uses two types of PET/CT scans (FDG and FAPI) to better see and track colorectal cancer that has spread to the belly lining (peritoneum). It aims to help doctors choose the best treatment by improving how they detect and monitor the cancer.
This trial studies how an FDG PET/CT scan (a special imaging test that looks for active cancer activity) can be used in people with high-risk primary or recurring breast cancer. It may help doctors better identify areas of concern and guide future care.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This trial tests a new type of PET scan called Ga-68-FAPI-46 to help find if your colorectal cancer has returned when your CEA levels are rising. It might offer a more accurate way to detect recurrence early.
Hear when a new Rectal Cancer Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.